TARSIER PHARMA

tarsier-pharma-logo

Tarsier Pharma is a late clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and inflammatory ocular diseases. The TRS Platform Technology is a bio-inspired immunomodulator designed to treat blinding inflammatory ocular diseases and is currently being developed as both eye drops and intravitreal injections. Ocular inflammations are a group of diseases affecting the front and back of the eye... . Non-infectious anterior and posterior uveitis is the most known ocular inflammatory disease. However, ocular inflammation is a critical underlying mechanism in the pathology of other inflammatory eye diseases, such as non-evaporative dry eye, diabetic macular edema (DME), and dry age-related macular degeneration (AMD). Hundreds of millions of people in all age groups are suffering from ocular inflammatory diseases worldwide, conditions that pose severe risks of vision loss and blindness.

#SimilarOrganizations #People #Financial #Event #Website #More

TARSIER PHARMA

Social Links:

Industry:
Biopharma Medical Pharmaceutical Therapeutics

Founded:
2016-01-01

Address:
Haifa, Hefa, Israel

Country:
Israel

Website Url:
http://www.tarsiuspharma.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
5.4 M USD

Technology used in webpage:
SPF Amazon Microsoft Exchange Online Office 365 Mail Google Apps For Business GoDaddy DNS AWS Global Accelerator


Similar Organizations

artax-biopharma-logo

Artax Biopharma

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

bichen-pharmaceutical-logo

Bichen Pharmaceutical

Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.

dmed-logo

dMed

dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies.

q32-bio-logo

Q32 Bio

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

Current Employees Featured

daphne-haim-langford_image

Daphne Haim-Langford
Daphne Haim-Langford CEO and Founder @ Tarsier Pharma
CEO and Founder

emilee-fulcher_image

Emilee Fulcher
Emilee Fulcher Vice President of Clinical Affairs @ Tarsier Pharma
Vice President of Clinical Affairs
2024-05-01

not_available_image

Zohar Milman
Zohar Milman COO @ Tarsier Pharma
COO

Founder


daphne-haim-langford_image

Daphne Haim-Langford

Investors List

horizon-2020_image

Horizon 2020

Horizon 2020 investment in Grant - Tarsier Pharma

sun-pharma_image

Sun Pharmaceutical Industries

Sun Pharmaceutical Industries investment in Corporate Round - Tarsier Pharma

Official Site Inspections

http://www.tarsiuspharma.com

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Tarsier Pharma"

Tarsier® Pharma

Science & Technology Dazdotuftide (TRS), the Tarsier breakthrough platform technology, approaches inflammatory diseases from within the immune system. Tarsier® Pharma …See details»

Tarsius Pharma Company Profile | Management and Employees …

Tarsius Pharma Profile and History Tarsius Pharma was established in 2016 and is focused on developing TRS, a breakthrough, bio-inspired platform technology for the treatment of blinding …See details»

Investor Relations - Tarsier® Pharma

Jan 16, 2024 Investor Relations Investor Relations CORPORATE PROFILE We are a clinical late-stage pharmaceutical company focused on the development and commercialization of …See details»

Our Leadership | Tarsus

Prior to joining Tarsus, he was a Senior Vice President of Global Pharmaceutical Development at Allergan (an AbbVie company), where he built strong and nimble early development functions …See details»

Tarsius Pharma - Overview, News & Competitors | ZoomInfo.com

View Tarsius Pharma (www.tarsiuspharma.com) location in Haifa, Israel , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

Tarsius Pharma - Company Profile & Staff Directory | ContactOut

Discover Tarsius Pharma company details, including staff directory, contact information, and industry insights. Explore alternatives, competitors, and frequently asked questions to get …See details»

Tarsier Pharma - Israeli Startup | Startup Nation Finder

Jan 5, 2022 Tarsier Pharma is a late-clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of …See details»

Tarsier Pharma Overview | SignalHire Company Profile

Mar 1, 2022 Tarsier Pharma is a late clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of …See details»

Tarsier Pharma - VentureRadar

Tarsius Pharma is a clinical stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and …See details»

Tarsius Pharma - Products, Competitors, Financials, Employees ...

Tarsius Pharma is a late clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune and inflammatory ocular diseases. The company's main …See details»

TARSIUS PHARMA LTD - VentureRadar

Tarsius Pharma is a clinical stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and …See details»

Tarsius Pharma - CoBee Company Profile & Funding Rounds

Tarsius Pharma is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of inflammatory ocular diseases.See details»

Tarsier Pharma - Contacts, Employees, Board Members

Tarsier Pharma is a late clinical-stage company that develops treatment for autoimmune and inflammatory ocular diseases.See details»

Tarsier Pharma 2025 Company Profile: Valuation, Funding

Information on valuation, funding, cap tables, investors, and executives for Tarsier Pharma. Use the PitchBook Platform to explore the full profile.See details»

Tarsier Pharma - VentureRadar

VentureRadar Research / Company Website Tarsius Pharma is a clinical stage company dedicated to the development and commercialization of a breakthrough therapeutic approach …See details»

Home | Tarsus

Mar 12, 2025 Creating novel therapies, beginning with the eye XDEMVY ® (lotilaner ophthalmic solution) 0.25% is the first and only FDA-approved product for the millions of patients living …See details»

Tarsier Pharma - Funding, Financials, Valuation & Investors

Tarsier Pharma is a late clinical-stage company that develops treatment for autoimmune and inflammatory ocular diseases.See details»

Press Release Distribution and Management - GlobeNewswire

GlobeNewswire specializes in the distribution and delivery of press releases, financial disclosures and multimedia content to the media and general public.See details»

Our Story | Tarsus

We push boundaries to find new ways forward – for our patients, physicians, employees and communities. Since our founding, we’ve been intentional about doing things differently – from …See details»

linkstock.net © 2022. All rights reserved